Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Sep 1;100(5):1047–1058. doi: 10.1172/JCI119615

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

G Wolf 1, F N Ziyadeh 1, F Thaiss 1, J Tomaszewski 1, R J Caron 1, U Wenzel 1, G Zahner 1, U Helmchen 1, R A Stahl 1
PMCID: PMC508279  PMID: 9276721

Abstract

Glomerular influx of monocytes/macrophages (M/M) occurs in many immune- and non-immune-mediated renal diseases. The mechanisms targeting M/M into the glomerulus are incompletely understood, but may involve stimulated expression of chemokines. We investigated whether angiotensin II (ANG II) induces the chemokine RANTES in cultured glomerular endothelial cells of the rat and in vivo. ANG II stimulated mRNA and protein expression of RANTES in cultured glomerular endothelial cells. The ANG II-induced RANTES protein was chemotactic for human monocytes. Surprisingly, the ANG II-stimulated RANTES expression was transduced by AT2 receptors because the AT2 receptor antagonists PD 123177 and CGP-42112A, but not an AT1 receptor blocker, abolished the induced RANTES synthesis. Intraperitoneal infusion of ANG II (500 ng/h) into naive rats for 4 d significantly stimulated glomerular RANTES mRNA and protein expression compared with solvent-infused controls. Immunohistochemistry revealed induction of RANTES protein mainly in glomerular endothelial cells and small capillaries. Moreover, ANG II- infused animals exhibited an increase in glomerular ED-1- positive cells compared with controls. Oral treatment with PD 123177 (50 mg/liter drinking water) attenuated the glomerular M/M influx without normalizing the slightly elevated systolic blood pressure caused by ANG II infusion, suggesting that the effects on blood pressure and RANTES induction can be separated. We conclude that the vasoactive peptide ANG II may play an important role in glomerular chemotaxis of M/M through local induction of the chemokine RANTES. The observation that the ANG II- mediated induction of RANTES is transduced by AT2 receptors may influence the decision as to which substances might be used for the therapeutic interference with the activity of the renin-angiotensin system.

Full Text

The Full Text of this article is available as a PDF (538.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ardaillou R. Angiotensin II type II receptor. Does it have a role in the normal or diseased kidney? Nephrol Dial Transplant. 1994;9(10):1364–1365. [PubMed] [Google Scholar]
  2. Brechler V., Reichlin S., De Gasparo M., Bottari S. P. Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Receptors Channels. 1994;2(2):89–98. [PubMed] [Google Scholar]
  3. Cattell V. Macrophages in acute glomerular inflammation. Kidney Int. 1994 Apr;45(4):945–952. doi: 10.1038/ki.1994.128. [DOI] [PubMed] [Google Scholar]
  4. Diamond J. R., Anderson S. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition. Am J Pathol. 1990 Dec;137(6):1323–1332. [PMC free article] [PubMed] [Google Scholar]
  5. Diamond J. R. Effects of dietary interventions on glomerular pathophysiology. Am J Physiol. 1990 Jan;258(1 Pt 2):F1–F8. doi: 10.1152/ajprenal.1990.258.1.F1. [DOI] [PubMed] [Google Scholar]
  6. Edwards R. M., Aiyar N. Angiotensin II receptor subtypes in the kidney. J Am Soc Nephrol. 1993 Apr;3(10):1643–1652. doi: 10.1681/ASN.V3101643. [DOI] [PubMed] [Google Scholar]
  7. Egido J. Vasoactive hormones and renal sclerosis. Kidney Int. 1996 Feb;49(2):578–597. doi: 10.1038/ki.1996.82. [DOI] [PubMed] [Google Scholar]
  8. Farber H. W., Center D. M., Rounds S., Danilov S. M. Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur Heart J. 1990 Apr;11 (Suppl B):100–107. doi: 10.1093/eurheartj/11.suppl_b.100. [DOI] [PubMed] [Google Scholar]
  9. Floege J., Burns M. W., Alpers C. E., Yoshimura A., Pritzl P., Gordon K., Seifert R. A., Bowen-Pope D. F., Couser W. G., Johnson R. J. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 1992 Feb;41(2):297–309. doi: 10.1038/ki.1992.42. [DOI] [PubMed] [Google Scholar]
  10. Giachelli C. M., Pichler R., Lombardi D., Denhardt D. T., Alpers C. E., Schwartz S. M., Johnson R. J. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 1994 Feb;45(2):515–524. doi: 10.1038/ki.1994.67. [DOI] [PubMed] [Google Scholar]
  11. Hahn A. W., Jonas U., Bühler F. R., Resink T. J. Activation of human peripheral monocytes by angiotensin II. FEBS Lett. 1994 Jun 27;347(2-3):178–180. doi: 10.1016/0014-5793(94)00531-1. [DOI] [PubMed] [Google Scholar]
  12. Harris R. C., Martinez-Maldonado M. Angiotensin II-mediated renal injury. Miner Electrolyte Metab. 1995;21(4-5):328–335. [PubMed] [Google Scholar]
  13. Heeger P., Wolf G., Meyers C., Sun M. J., O'Farrell S. C., Krensky A. M., Neilson E. G. Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. Kidney Int. 1992 Jan;41(1):220–225. doi: 10.1038/ki.1992.31. [DOI] [PubMed] [Google Scholar]
  14. Huber A. R., Kunkel S. L., Todd R. F., 3rd, Weiss S. J. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991 Oct 4;254(5028):99–102. doi: 10.1126/science.1718038. [DOI] [PubMed] [Google Scholar]
  15. Jardine A. G. Angiotensin II and glomerulonephritis. J Hypertens. 1995 May;13(5):487–493. doi: 10.1097/00004872-199505000-00002. [DOI] [PubMed] [Google Scholar]
  16. Johnson R. J., Alpers C. E., Yoshimura A., Lombardi D., Pritzl P., Floege J., Schwartz S. M. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992 May;19(5):464–474. doi: 10.1161/01.hyp.19.5.464. [DOI] [PubMed] [Google Scholar]
  17. Kambayashi Y., Bardhan S., Takahashi K., Tsuzuki S., Inui H., Hamakubo T., Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993 Nov 25;268(33):24543–24546. [PubMed] [Google Scholar]
  18. Klahr S., Ishidoya S., Morrissey J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis. 1995 Jul;26(1):141–146. doi: 10.1016/0272-6386(95)90167-1. [DOI] [PubMed] [Google Scholar]
  19. Kobayashi S., Ohnishi J., Nibu Y., Nishimatsu S., Umemura S., Ishii M., Murakami K., Miyazaki H. Cloning of the rat angiotensin II type 2 receptor gene and identification of its functional promoter region. Biochim Biophys Acta. 1995 Jun 9;1262(2-3):155–158. doi: 10.1016/0167-4781(95)00076-s. [DOI] [PubMed] [Google Scholar]
  20. Lafayette R. A., Mayer G., Park S. K., Meyer T. W. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1992 Sep;90(3):766–771. doi: 10.1172/JCI115949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lee L. K., Meyer T. W., Pollock A. S., Lovett D. H. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest. 1995 Aug;96(2):953–964. doi: 10.1172/JCI118143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lee S. K., Jin S. Y., Han D. C., Hwang S. D., Lee H. B. Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats. Nephrol Dial Transplant. 1993;8(12):1338–1343. [PubMed] [Google Scholar]
  23. Leonard E. J., Yoshimura T., Skeel A., Goodwin R. A multiwell cell settling and adherence chamber for morphology and differential counting. Biotechniques. 1990 Dec;9(6):684, 686, 688-9. [PubMed] [Google Scholar]
  24. Lo M., Liu K. L., Lantelme P., Sassard J. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest. 1995 Mar;95(3):1394–1397. doi: 10.1172/JCI117792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol. 1995 Feb 15;154(4):1870–1878. [PubMed] [Google Scholar]
  26. Mukoyama M., Nakajima M., Horiuchi M., Sasamura H., Pratt R. E., Dzau V. J. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 1993 Nov 25;268(33):24539–24542. [PubMed] [Google Scholar]
  27. Nathan C. F. Secretory products of macrophages. J Clin Invest. 1987 Feb;79(2):319–326. doi: 10.1172/JCI112815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nikolic-Paterson D. J., Lan H. Y., Hill P. A., Atkins R. C. Macrophages in renal injury. Kidney Int Suppl. 1994 Feb;45:S79–S82. [PubMed] [Google Scholar]
  29. Oppenheim J. J., Zachariae C. O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991;9:617–648. doi: 10.1146/annurev.iy.09.040191.003153. [DOI] [PubMed] [Google Scholar]
  30. Pattison J., Nelson P. J., Huie P., von Leuttichau I., Farshid G., Sibley R. K., Krensky A. M. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet. 1994 Jan 22;343(8891):209–211. doi: 10.1016/s0140-6736(94)90992-x. [DOI] [PubMed] [Google Scholar]
  31. Rosenberg M. E., Chmielewski D., Hostetter T. H. Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest. 1990 Apr;85(4):1144–1149. doi: 10.1172/JCI114546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today. 1992 Aug;13(8):291–294. doi: 10.1016/0167-5699(92)90039-A. [DOI] [PubMed] [Google Scholar]
  33. Schall T. J. Biology of the RANTES/SIS cytokine family. Cytokine. 1991 May;3(3):165–183. doi: 10.1016/1043-4666(91)90013-4. [DOI] [PubMed] [Google Scholar]
  34. Schlöndorff D. The role of chemokines in the initiation and progression of renal disease. Kidney Int Suppl. 1995 Jun;49:S44–S47. [PubMed] [Google Scholar]
  35. Schreiner G. F. The role of the macrophage in glomerular injury. Semin Nephrol. 1991 May;11(3):268–275. [PubMed] [Google Scholar]
  36. Sechi L. A., Grady E. F., Griffin C. A., Kalinyak J. E., Schambelan M. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol. 1992 Feb;262(2 Pt 2):F236–F240. doi: 10.1152/ajprenal.1992.262.2.F236. [DOI] [PubMed] [Google Scholar]
  37. Stahl R. A., Paravicini M., Schollmeyer P. Angiotensin II stimulation of prostaglandin E2 and 6-keto-F1 alpha formation by isolated human glomeruli. Kidney Int. 1984 Jul;26(1):30–34. doi: 10.1038/ki.1984.130. [DOI] [PubMed] [Google Scholar]
  38. Stahl R. A., Thaiss F., Disser M., Helmchen U., Hora K., Schlöndorff D. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int. 1993 Nov;44(5):1036–1047. doi: 10.1038/ki.1993.346. [DOI] [PubMed] [Google Scholar]
  39. Stoll M., Steckelings U. M., Paul M., Bottari S. P., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995 Feb;95(2):651–657. doi: 10.1172/JCI117710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Stoscheck C. M. Quantitation of protein. Methods Enzymol. 1990;182:50–68. doi: 10.1016/0076-6879(90)82008-p. [DOI] [PubMed] [Google Scholar]
  41. Takahashi M., Masuyama J., Ikeda U., Kitagawa S., Kasahara T., Saito M., Kano S., Shimada K. Suppressive role of endogenous endothelial monocyte chemoattractant protein-1 on monocyte transendothelial migration in vitro. Arterioscler Thromb Vasc Biol. 1995 May;15(5):629–636. doi: 10.1161/01.atv.15.5.629. [DOI] [PubMed] [Google Scholar]
  42. Takahasi K., Bardhan S., Kambayashi Y., Shirai H., Inagami T. Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2. Biochem Biophys Res Commun. 1994 Jan 14;198(1):60–66. doi: 10.1006/bbrc.1994.1009. [DOI] [PubMed] [Google Scholar]
  43. Thaiss F., Haas C., Helmchen U., Wenzel U., Stahl R. A. Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology. Nephrol Dial Transplant. 1996 Jan;11(1):40–46. [PubMed] [Google Scholar]
  44. Van Goor H., Ding G., Kees-Folts D., Grond J., Schreiner G. F., Diamond J. R. Macrophages and renal disease. Lab Invest. 1994 Oct;71(4):456–464. [PubMed] [Google Scholar]
  45. Vissers M. C., Jester S. A., Fantone J. C. Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN. J Immunol Methods. 1988 Jun 13;110(2):203–207. doi: 10.1016/0022-1759(88)90104-4. [DOI] [PubMed] [Google Scholar]
  46. Weinstock J. V., Kassab J. T. Angiotensin II stimulation of granuloma macrophage phagocytosis and actin polymerization in murine schistosomiasis mansoni. Cell Immunol. 1984 Nov;89(1):46–54. doi: 10.1016/0008-8749(84)90196-5. [DOI] [PubMed] [Google Scholar]
  47. Wenzel U. O., Abboud H. E. Chemokines and renal disease. Am J Kidney Dis. 1995 Dec;26(6):982–994. doi: 10.1016/0272-6386(95)90065-9. [DOI] [PubMed] [Google Scholar]
  48. Wenzel U. O., Fouqueray B., Grandaliano G., Kim Y. S., Karamitsos C., Valente A. J., Abboud H. E. Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. Circ Res. 1995 Sep;77(3):503–509. doi: 10.1161/01.res.77.3.503. [DOI] [PubMed] [Google Scholar]
  49. Wolf G., Aberle S., Thaiss F., Nelson P. J., Krensky A. M., Neilson E. G., Stahl R. A. TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int. 1993 Oct;44(4):795–804. doi: 10.1038/ki.1993.314. [DOI] [PubMed] [Google Scholar]
  50. Wolf G., Mueller E., Stahl R. A., Ziyadeh F. N. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest. 1993 Sep;92(3):1366–1372. doi: 10.1172/JCI116710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wolf G., Neilson E. G. Angiotensin II as a renal growth factor. J Am Soc Nephrol. 1993 Mar;3(9):1531–1540. doi: 10.1681/ASN.V391531. [DOI] [PubMed] [Google Scholar]
  52. Wolf G., Zahner G., Schroeder R., Stahl R. A. Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant. 1996 Feb;11(2):263–269. doi: 10.1093/oxfordjournals.ndt.a027251. [DOI] [PubMed] [Google Scholar]
  53. Wolf G., Ziyadeh F. N., Zahner G., Stahl R. A. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension. 1996 Apr;27(4):897–905. doi: 10.1161/01.hyp.27.4.897. [DOI] [PubMed] [Google Scholar]
  54. Yamamoto Y., Yamamguchi T., Shimamura M., Hazato T. Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes. Biochem Biophys Res Commun. 1993 Jun 30;193(3):1038–1043. doi: 10.1006/bbrc.1993.1729. [DOI] [PubMed] [Google Scholar]
  55. Young B. A., Johnson R. J., Alpers C. E., Eng E., Gordon K., Floege J., Couser W. G., Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 1995 Mar;47(3):935–944. doi: 10.1038/ki.1995.139. [DOI] [PubMed] [Google Scholar]
  56. Zhuo J., Song K., Harris P. J., Mendelsohn F. A. In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney. Ren Physiol Biochem. 1992 Sep-Oct;15(5):231–239. doi: 10.1159/000173458. [DOI] [PubMed] [Google Scholar]
  57. von Luettichau I., Nelson P. J., Pattison J. M., van de Rijn M., Huie P., Warnke R., Wiedermann C. J., Stahl R. A., Sibley R. K., Krensky A. M. RANTES chemokine expression in diseased and normal human tissues. Cytokine. 1996 Jan;8(1):89–98. doi: 10.1006/cyto.1996.0012. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES